The mechanisms underlying the hypolipidaemic effects of atromid S, nicotinic acid and benzalecene. I. The metabolism of free fatty acid-albumin complex by the isolated perfused liver.
D000418:Albumins / Q000378:metabolism*; D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001835:Body Weight; D002087:Butyrates / Q000494:pharmacology*; D002247:Carbon Isotopes; D002784:Cholesterol / Q000378:metabolism; D004032:Diet; D005989:Glycerides / Q000378:metabolism; D066298:In Vitro Techniques; D050356:Lipid Metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D008298:Maleates / Q000494:pharmacology*; D009539:Nicotinic Acids / Q000494:pharmacology*; D009929:Organ Size; D010084:Oxidation-Reduction; D010169:Palmitic Acids / Q000378:metabolism*; D010477:Perfusion; D010743:Phospholipids / Q000378:metabolism; D051381:Rats; D014280:Triglycerides / Q000378:metabolism
D000418:Albumins; D000924:Anticholesteremic Agents; D002087:Butyrates; D002247:Carbon Isotopes; D005989:Glycerides; D008298:Maleates; D009539:Nicotinic Acids; D010169:Palmitic Acids; D010743:Phospholipids; D014280:Triglycerides; D002784:Cholesterol